BioSpace News Archive

Qkine, an industry-leading manufacturer of animal-free, highly pure recombinant proteins, is delighted to announce a sales distribution agreement with Thomas Scientific to enable fast and easy purchasing of Qkine growth factors and cytokines for stem cell scientists based in the United States.

Dipharma Francis S.r.l., a leading Contract Development and Manufacturing Organization and a global manufacturer of Active Pharmaceutical Ingredients, announced another new production site of the Group, thefacility located in Caronno Pertusella, near Milan, has received the Good Manufacturing Practice certification - CBPF - from the Regulatory Authority of Brazil, ANVISA.

Tiamat Sciences and BIOMILQ, two women-owned and led biotechnology startups in Research Triangle Park, NC, have collaborated on a project demonstrating that a plant-based recombinant protein, Human Prolactin, is just as effective as the commercially available alternative, and it’s ten times more affordable.

Caris Life Sciences® announced that Sarah Cannon Research Institute, one of the world’s leading oncology research organizations conducting community-based clinical trials, has joined the Caris Precision Oncology Alliance™.

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following scientific and industry conferences in November.

Boston Scientific Corporation generated net sales of $3.527 billion during the third quarter of 2023, growing 11.2 percent on a reported basis, 11.1 percent on an operational1 basis and 10.2 percent on an organic2 basis, all compared to the prior year period.

Pfizer Inc. and BioNTech SE announced positive topline results from a Phase 1/2 study evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age.

Merck, known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2023.

Chimerix announced that it will host a live conference call and audio webcast on Thursday, November 2, 2023 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2023, and to provide a business overview.

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, will report third quarter 2023 financial results on November 2, 2023, and will host a conference call at 8:00 a.m. ET that day.